News | TCTAP 2022
News TCTAP
News | TCTAP 2022
Was 2021 a bad year for FFR-guided PCI?
William F. Fearon, MD says analysis of FUTURE, FLOWER-MI and FAME 3 trials show FFR-guided PCI still beneficial for select patients with multivessel CAD
News | TCTAP 2022
¡®CABG helps people live longer¡¯
Cardiac surgeon S. Christopher Malaisrie, MD says CABG improves survival for MVD and LMCAD, despite recent guideline downgrades
News | TCTAP 2022
Is CABG the best approach for multivessel, left main CAD?
Mario F.L. Gaudino, MD says PCI and CABG are complementary - not antagonistic – strategies for patients with MVD, LMCAD
News | TCTAP 2022
¡®Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy¡¯
Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones
ISSN: 3058-6437 | °£Ç๰µî·Ï¹øÈ£: ¼ÛÆÄ,¸¶00061 | µî·ÏÀÏÀÚ: 2024³â 10¿ù 10ÀÏ | ¹ßÇàÀÎ/ÆíÁýÀÎ: ¹Ú½ÂÁ¤